German drugmaker Boehringer Ingelheim and Click Therapeutics said their phase 3 trial of a prescription digital therapeutic for the negative symptoms of schizophrenia met its primary endpoint. Data ...

The digital therapeutics (DTx) market is emerging as one of the fastest-growing sectors in healthcare, centered on the ...

In response to Anika Kumar and colleagues’ investigation into prescription digital therapeutics (November 2023), I agree that evaluating evidence and inclusivity is critical for this emerging field.

The study met its primary endpoint demonstrating a significant reduction in experiential negative symptoms with CT-155. For patients with schizophrenia experiencing negative symptoms, the addition of ...

Investments in the digital health sector dipped substantially last year compared to the prior year, from $15.3 billion in 2022 to $10.7 billion in 2023. While funding in the industry has decreased, so ...

Psychiatric disorders represent a major public health challenge in the United States and contribute to significant morbidity and health care costs. In 2022, mental health conditions affected more than ...

Credit: Getty Images Prescription digital therapeutics represent the evolving intersection of technology and mental health care – but how do clinicians feel about this new era? The recent ...

But whereas Martucci’s definition of a digital therapeutic was broad, Waldron’s vision of proper digital therapeutics includes some very clear requirements: randomized controlled trials, Current Good ...

We close out May’s Mental Health Awareness Month with a landmark FDA regulatory decision that could have a great impact on mental health across the country. In a watershed moment for digital health ...

DirectTrust and Digital Therapeutics Alliance can move forward by showing payers their product is suitable for coverage, says Scott Stuewe, president and CEO of DirectTrust, and Andy Molnar, CEO of ...